Trials / Completed
CompletedNCT07508345
Endothelial Dysfunction as a Predictive Marker of Acute Graft-Versus-Host Disease in Adult Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Endothelial Dysfunction as a Predictive Marker of Acute Graft-Versus-Host Disease in Adult Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (END-GAME)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Assess whether the CEC count in peripheral blood, analyzed at baseline T0, can predict the risk of acute GvHD onset.
Conditions
Timeline
- Start date
- 2021-06-04
- Primary completion
- 2022-07-31
- Completion
- 2023-07-31
- First posted
- 2026-04-02
- Last updated
- 2026-04-02
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT07508345. Inclusion in this directory is not an endorsement.